Related Experiment Videos
[Kleine-Levin-syndrome (author's transl)]
Wiener Medizinische Wochenschrift (1946)
|June 15, 1980
Summary
Kleine-Levin syndrome, a rare neurological disorder, can manifest with nausea, vertigo, and prolonged sleep episodes. This case highlights potential hypothalamic dysfunction and suggests methylphenidate-hydrochloride as a treatment option.
Area of Science:
- Neurology
- Pediatric Neurology
Background:
- Kleine-Levin syndrome (KLS) is a rare neurological disorder characterized by recurrent episodes of hypersomnia and cognitive or behavioral disturbances.
- This report details a case study of an 18-year-old female diagnosed with KLS four years after menarche.
Observation:
- The patient initially presented with episodes of nausea and vertigo.
- Over time, these symptoms evolved to include prolonged periods of hypersomnia.
- Neurological examination revealed minimal overirritability of the right vestibular system and mild hypersensitivity to touch and pain on the right side.
- A disturbed water balance, specifically retention, was also noted.
Findings:
- The clinical presentation suggests a potential disturbance in hypothalamic regulation.
- The combination of neurological and autonomic symptoms points towards complex central nervous system involvement.
Implications:
- Early recognition of KLS symptoms is crucial for timely diagnosis and management.
- Methylphenidate-hydrochloride (Rilatin) is proposed as a therapeutic agent for managing KLS symptoms.
- Further research into hypothalamic dysfunction in KLS may elucidate underlying pathophysiological mechanisms.